GLUE•benzinga•
Monte Rosa Therapeutics shares are trading lower after the company announced the pricing of a $100 million public offering.
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 16, 2024 by benzinga